Abstract
Although case-control studies suggest that African Americans with common coding variants in the APOL1 gene are 5-29 timesmore likely than those individuals without such variants to have focal segmental glomerulosclerosis, HIV-associated nephropathy, or ESRD, prospective studies have not yet evaluated the impact of these variants on CKD in a community-based sample of African Americans. Here, we studied whether the APOL1 G1 and G2 risk alleles associate with the development of CKD and progression to ESRD by analyzing data from3067 African Americans in the Atherosclerosis Risk in Communities Study who did not have CKD at baseline.Carryingtwo risk alleles associatedwith a 1.49-fold increased risk ofCKD(95%CI=1.02 to 2.17) and a 1.88-fold increased risk of ESRD (95% CI=1.20 to 2.93) compared with zero or one risk allele; associations persisted after adjusting for European ancestry. Among participants who developed CKD, those participants with two risk alleles were more likely to progress to ESRD than their counterparts with zero or one risk allele (HR=2.22, 95% CI=1.01 to 4.84). In conclusion, APOL1 risk variants are risk factors for the development of CKD and progression from CKD to ESRD among African Americans in the general population.
Original language | English (US) |
---|---|
Pages (from-to) | 1484-1491 |
Number of pages | 8 |
Journal | Journal of the American Society of Nephrology |
Volume | 24 |
Issue number | 9 |
DOIs | |
State | Published - Sep 2013 |
ASJC Scopus subject areas
- General Medicine